{"url_path":"/fda/drug/recalls/D-0657-2026","section_key":"summary","section_title":"DRUG Recall: Boehringer Ingelheim Pharmaceuticals, Inc. — Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA.  NDC: 00597-0300-45","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-06-12","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0657-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Boehringer Ingelheim Pharmaceuticals, Inc."},"word_count":96,"has_tables":false,"body_markdown":null}